Neurotrophic effects of immunophilin ligands have been shown in animal models of peripheral and central nervous system insult. To investigate the specific growth-promoting effects of these compounds, we examined the effects of various immunophilin ligands on primary dopamine (DA) neurons in culture and compared these with a well-known DA trophic factor, glial cell line-derived neurotrophic factor (GDNF). In neuronal cultures from Embryonic Day 14 ventral mesencephalon, enhanced elongation of DA neurites was observed with immunophilin ligands, which inhibited the phosphatase activity of calcineurin (FK506 and cyclosporin A) when compared to vehicle-treated cultures. This elongation was also observed with GDNF, known to exert its trophic effects through phosphorylation-dependent pathways. In contrast, immunophilin ligands that do not inhibit calcineurin (rapamycin and V-10,367) increased branching of DA neurites, suggesting that elongation is dependent upon maintained phosphorylation while branching is not. In addition, both V-10,367 and rapamycin antagonized the elongation effects of FK506 and induced branching. The antagonism of elongation (and reappearance of branching) illustrates the intrinsic abilities of developing DA neurons to either elongate or branch, but not both. We show that the immunophilin FKBP12 (12-kDa FK506-binding protein) is expressed in ventral mesencephalic neuronal cultures and colocalizes with DA neurons. This work elucidates the specific growth-promoting effects by which GDNF and immunophilin ligands modify developmental growth processes of DA neurons, via their interactions with intracellular targets.
INTRODUCTION
The regulation of neurite elongation and branching is fundamental for establishing neuronal circuitry (49, 59) . Recently, immunosuppressive drugs such as FK506 and cyclosporin A (CsA) have been shown to enhance neurite outgrowth from various cell lines and peripheral nerve preparations (50, 67) , as well as primary CNS neurons in culture (10) . These compounds also protect against peripheral and central nervous system insult (10, 26, 65, 70) , alter long term potentiation, (LTP) and long term depresssion, (LTD) (21, 73) , increase the rate of peripheral nerve regeneration (25) , and regulate neurotransmitter release (58, 69) . The observed effects are partially or fully mediated by specific intracellular pathways that are affected by these ligands, but that remain unclear in the context of neuronal cell systems. In the immune system, the immunophilin ligand FK506 complexes with the immunophilin FKBP12 (12-kDa FK506-binding protein). This drug-immunophilin complex then binds to and inhibits the phosphatase activity of calcineurin (48) , augmenting the phosphorylation of several substrates (12, 28, 42, 52, 64, 68) , which leads to inhibition of cytokine synthesis and immunosuppression (20) . Cyclosporin A also inhibits calcineurin, but through its interaction with the immunophilin cyclophilin B.
High levels of FKBP12 and cyclophilin in the brain (68) and their colocalization with calcineurin suggested that the neuronal trophic effects may also act through this intracellular pathway. The neuroprotective effects seen with immunophilin ligands in models of neurodegenerative disorders have led to the design of smallmolecule ligands that bind to immunophilins, but are not immunosuppressive (do not interact with calcineurin (3)). One of these novel immunophilin ligands, V-10,367, has an affinity to FKBP12 similar to that of FK506 (K i of 0.5 nM) and does not decrease the phosphatase activity of calcineurin (3) . However, trophic effects are retained even in the absence of calcineurin inhibition: V-10,367 potentiates neuronal growth factor (NGF)-induced neurite outgrowth from immortalized cells in culture (26) . In addition, neuroprotective and regenerative effects of these novel immunophilin ligands have been obtained in animal models of peripheral and central nervous system insult (10, 26, 70) . We recently demonstrated neurotrophic effects of V-10,367 in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease (10) . Striatal dopaminergic (DA) innervation was spared from MPTP-induced degeneration in animals orally treated with V-10,367, while treatment with FK506 did not cause this effect. These studies suggest that inhibition of this phosphatase may not be required for the trophic effects obtained with these ligands in the nervous system.
To determine the specific effects of these compounds on the DA system, we evaluated the growth-promoting effects of these molecules on primary ventral mesencephalic (VM) DA neurons in culture. Comparisons were made between immunophilin ligands that interact with different intracellular targets and the trophic effects of glial cell line-derived neurotrophic factor (GDNF).
MATERIALS AND METHODS

Primary Ventral Mesencephalic Cultures
Primary cultures of DA neurons (previously shown to be 95% neuronal) were obtained from E14 SpragueDawley rat (Charles River, MA) ventral mesencephalon (VM) as described previously (10, 11) . Briefly, tissue was dissociated by incubation in 0.025% trypsin solution (37°C, 15 min; Sigma) and triturated in a solution of DNAse (0.01%; Sigma) and trypsin inhibitor (0.05%; Sigma). Isolated cells were resuspended in Dulbecco's modified Eagle's medium (DMEM; Gibco, NY) containing heat-inactivated horse serum (10%), glucose (6.0 mg/ml), penicillin (10,000 U/ml), streptomycin (10 mg/ml; Sigma), and glutamine (2 mM; Gibco). Five hundred microliters of suspension containing 5 ϫ 10 5 cells/ml was plated into each well of 24-well trays (Falcon), precoated with poly-L-lysine (Sigma), containing 500 l of serum-containing (Sϩ) medium. Unattached cells were aspirated after 1 h, and 1 ml of fresh Sϩ medium containing immunophilin ligands (Table 1) , GDNF, or vehicle (DMSO diluted at equivalent concentrations (1:1000) per well) was added. At 1 day in culture, the medium was replaced with defined medium (containing N2 cocktail; Gibco) containing immunophilin ligands or GDNF (using 30 kDa as the molecular weight of GDNF, the doses of 0.001-100 ng/ml convert to 33 pM-3.3 nM). At 2 days in vitro (DIV), cultures were fixed for 1 h with 4% paraformaldehyde/4% sucrose in phosphate-buffered saline (PBS).
Immunohistochemistry
Cells were incubated in primary antibody against tyrosine hydroxylase (TH; 1:500; Pel-Freez, Rogers, AK) for 48 h at 4°C; antibody binding was visualized with reaction in 0.05% 3,3Ј-diaminobenzidine (DAB, Sigma). To study the expression of the immunophilin FKBP12 within VM neurons, cultures were doublelabeled with antibodies against TH and FKBP12 (1: 2000; Pharmingen, CA) and processed for immunocytochemical detection with texas red-and fluoresceinconjugated secondary antibody (1:200; Jackson ImmunoResearch; West Grove, PA). Fluorescent images of double-labeled FKBP12 and TH was visualized using a confocal argon laser scanning microscope (Leika), processed with Leika Physiology Module Software.
Quantification of Neuron Survival and Neurite Outgrowth
For neuron survival, four random fields at each corner of each well were selected for cell counts, as previously described (10): at 200ϫ magnification, and using an eyepiece grid, the number of cells in each 200 ϫ 20-m corner and center of the grid was counted (5 counts per field). Counts consisted of the total number of neurons in each grid region for neuronal viability (defined morphologically in phase contrast and confirmed by trypan blue exclusion test), as well as the number of THϩ neurons. For analysis of neurite elongation and branching, two fields from opposite sides of each well were captured in Adobe Photoshop, and 10 randomly chosen THϩ neurons per field were analyzed. Each neurite from a THϩ neuron was traced and measured (in millimeters) to determine elongation effects, and the number of neurites extending from a single THϩ neuron was counted to determine branching effects (Fig. 1) . The measurements from the 10 THϩ neurons per field were averaged to obtain two measurements per well. Each dose of each compound was run in duplicate per experiment, and data are expressed as percentage control from two to four pooled experiments (each dose in duplicate per experiment, for n ϭ 8-16 per dose). All comparisons were evaluated using analysis of variance (ANOVA) in JMP Version 3.1 (SAS Institute, NC). When significance was obtained, post-hoc Tukey-Kramer HSD was performed to compare significant differences between groups (*P Ͻ 0.05). Error bars represent SEM. 
RESULTS
To better define intracellular targets and mechanisms of the trophic effects observed with immunophilin ligands, we utilized a system of primary DA neurons from E14 VM. By immunostaining VM cultures for TH (used here as a marker for DA neurons, Fig. 1 ) we investigated the effects of immunophilin ligands (Table 1 ) on neurite outgrowth. After 2 days in culture, the vehicle-treated primary DA neurons developed fairly short, unbranched THϩ neurites (Fig. 1A) . Treatment of cultures for 2 days with the immunophilin ligand V-10,367 produced a significantly larger number of neurites from each THϩ neuron (Fig. 1B) , whereas treatment with FK506 increased the length of neurites from THϩ neurons (Fig. 1C) . We quantified these effects as previously described (10) . Briefly, each neurite from a THϩ neuron was traced and measured (in millimeters) to determine its length (elongation), and the number of neurites extending from each THϩ neuron was counted (branching). To determine effects of immunophilin ligands or GDNF on neuronal viability, the total numbers of surviving neurons were analyzed: quantification revealed no effect of treatment with any of the immunophilin ligands or GDNF on total number of neurons (mean number of neurons per field ϭ 128.75; P Ͼ 0.768) or THϩ neurons (mean number of THϩ neurons per field ϭ 8.31; P Ͼ 0.258) after 2 days in culture.
Elongation of Developing DA Neurites
To compare the trophic effects of immunophilin ligands to a well-known trophic factor for DA neurons, we first determined the specific effects of GDNF on neurite development. Neurite outgrowth was significantly influenced by 2-day treatment with GDNF ( Fig.  2A) : the average length of THϩ neurites was significantly longer than that of those in vehicle-treated cultures at a range of doses. We then compared this effect with two immunophilin ligands; FK506 (Fig. 2B) and CsA ( Fig. 2C ) that bind their respective immunophilins and subsequently inhibit calcineurin. Both FK506 and CsA significantly enhanced elongation of neurites from THϩ neurons. We then analyzed two immunophilin ligands that do not inhibit calcineurin: V-10,367 (Fig.  2D ) and rapamycin (Fig. 2E ). These compounds had no effect on the length of THϩ neurites. Interestingly, rapamycin showed a significant decrease in the length of neurites at some doses (Fig. 2E) .
Branching of Developing DA Neurites
We next determined whether GDNF could affect the number of neurites extending from primary DA neurons. In contrast to elongation, neurite branching was not enhanced with GDNF (Fig. 3A) . On the contrary, there tended to be fewer neurites per THϩ neuron than in vehicle-treated cultures at one dose. FK506 did not enhance branching at the doses that caused elongation of neurites (Fig. 3B) ; however, at one low dose (0.01 M), a higher number of neurites was observed. The immunophilin ligand CsA had no effect on branching (Fig. 3C) . In contrast, the two compounds that do not inhibit calcineurin (V-10,367 and rapamycin) showed significantly enhanced branching of THϩ neurites (Figs. 3D and 3E, respectively) . The most robust effect with V-10,367 was observed at 0.05 M, when DA neurons developed 2ϫ the number of THϩ neurites that the vehicle-treated cultures developed.
Relationship between Branching and Elongation of Developing DA Neurites
In all cases where a compound produced a significant effect on DA neurite development (as previously ob- 
FIG. 3.
Branching of developing DA neurites. Number of THϩ neurites (percentage control) from primary cultures of E14 VM after 2 days of treatment. GDNF showed a decrease in branching of THϩ neurites only at the lowest dose (A), while FK506 showed a slight branching effect at its lowest dose (B). CsA showed no effect on branching of THϩ neurites (C). V-10,367 (D) and rapamycin (E), compounds that do not inhibit the phosphatase calcineurin, both showed significantly enhanced branching of THϩ neurites. Tukey-Kramer HSD, *P Ͻ 0.05; error bars represent SEM.
served with classic neurotrophic factors (36)), a bellshaped dose-response curve was apparent (see Figs. 2  and 3) . In several cases when neurons showed enhanced elongation they did not simultaneously show increased branching, and vice versa. For instance, two doses of rapamycin (0.05 and 0.1 M) significantly enhanced branching (Fig. 3E ), whereas these doses showed significantly shorter THϩ neurites (Fig. 2E) . Conversely the elongation produced by 0.005 and 0.01 M CsA (Fig. 2C ) was paralleled by a trend toward decreased branching at these doses (Fig. 3C) . Similarly, the only dose of FK506 that did induce branching (0.01 M, Fig. 3B) showed the lowest value of neurite length (Fig. 2B) .
Pharmacological Targets of Trophic Effects
To further define the intracellular mechanisms involved in the elongation and branching observed, we determined the presence of the immunophilin FKBP12 in VM cultures. FKBP12 was expressed in these neurons after 2 days in culture (Fig. 4A ) and colocalized with THϩ neurons (Figs. 4B and 4C ). We used combinations of V-10,367 or rapamycin with FK506 to determine whether the elongation effect of FK506 involved signaling through calcineurin via its interaction with FKBP12. Rapamycin and V-10,367 also bind FKBP12 and compete with FK506 for FKBP12 binding sites. FK506 (1.0 M) did not elongate THϩ neurites in the presence of V-10,367 or rapamycin (0.5 and 1.0 M, Fig. 4D ). This effect was observed with 0.5 M FK506 as well (data not shown). However, V-10,367 and rapamycin were able to induce branching in the presence of FK506 (Fig. 4E) .
DISCUSSION
Distinct Growth-Promoting Effects of Immunophilin Ligands
In the present study, we show that immunophilin ligands can enhance branching or elongation of neurite outgrowth from DA neurons. The identification of distinct aspects of neurite development allowed us to pharmacologically dissect specific effects of various immunophilin ligands and compare their effects with those of GDNF. The distinction between branching and elongation of neurites has previously been demonstrated when developing DA neurons are grown in the presence of growth factors (1, 5, 71) or their target striatal cells (14, 34, 62) . For instance, exposure of VM neurons to conditioned medium from VM induces growth of dendrite-like neurites (short with a high number of branches), while striatal-conditioned medium stimulates growth of axon-like neurites (62) . Though we did not differentiate between axons and dendrites (90% of neurites were MAPϩ, making selective analysis unreliable, Costantini et al., unpublished observations), independent regulation of axonal and dendritic initiation and elongation from DA neurons may play a role in the effects observed here. Studies have shown GDNF-induced neurite outgrowth from peripheral (16, 44) and VM neurons in culture (18, 36, 47) or after transplantation of VM tissue into adult brain (2, 29, 40, 61, 63, 80) . Though the most prominent influence of GDNF upon developing DA neurons is enhanced survival (17, 43, 46) , we did not observe this effect, most likely due to the short time course of our studies.
Several studies have observed enhanced neurite outgrowth with immunophilin ligands that do not inhibit calcineurin (26, 67) ; however these studies utilized transformed cell lines (dependent on NGF for outgrowth) and DRG explants and did not quantify differences between elongation and branching. The primary DA neuron cultures used in the present study were chosen as a more physiologic system for analyzing neurite outgrowth than growth factor-responsive cell lines or peripheral culture systems.
Generally, growth-promoting effects of neurotrophic factors depend on receptor activation. The primary intracellular receptors for the immunophilin ligands are FKBPs and cyclophilins, immunophilins that are highly expressed in the adult rat brain (13, 68) . The expression of FKBP12 in fetal VM cultures shown here suggests a physiological role for this protein in developing DA neurons. The observed expression of FKBP12 in all cells in VM cultures suggests that the immunophilin ligands may also affect the GABA neurons present in these cultures. However, these GABA neurons do not extend neurites to the same extent as DA neurons after 2 days in culture. GABA markers stained approximately 90% of the cells and neurites, making analysis of neurites from individual cells unreliable. No obvious changes in neurite outgrowth were observed in this neuronal population after treatment with immunophilin ligands or GDNF (Costantini et al., unpublished observations). Alternatively, the immunophilin ligands may be acting through other immunophilins such as FKBP13 (77), FKBP25 (22) , or FKBP52 (24, 72) .
The receptor for CsA is the immunophilin cyclophilin (31), also expressed in the substantia nigra (13) . Though CsA shows an affinity for its immunophilin that is 10-fold lower than FK506 has for FKBP12 (67), we observed enhanced elongation at lower doses with CsA than with FK506. This suggests that pathways other than the CsA/cyclophilin interaction may be involved. In contrast to our results, CsA prevented axonal elongation in cultured cerebellar neurons with no effect on neurite formation (19) and did not increase axonal regeneration in the sciatic nerve model (78) , suggesting that cyclophilin-mediated trophic effects may not be active in these specific neuronal systems.
The bell-shaped immunophilin ligand dose-response curves in the present study suggest an optimal immunophilin ligand concentration for maximal trophic effects. Such effects have previously been explained by the "set-point hypothesis" of both growth factors and Caϩ levels (41, 55) , where optimal trophic effects are observed with a mid level of growth factor or Caϩ level and low or high levels produce suboptimal or even toxic effects. Consistent with our present results (though inherent variability may also be responsible for the bell shapes of these curves), a bell-shaped dose-response curve has been observed for optimal trophic effects of GDNF and FK506 (36, 78) . Neurite sprouting and elongation are promoted only when intracellular Ca 2ϩ levels are within a permissive range (53) (54) (55) 60) . Immunophilin ligands have been shown to regulate Caϩ levels via their interactions with two Ca 2ϩ channels found in the brain, the ryanodine receptor (RyR), and the inositol triphosphate receptor (IP3R) (7, 8, 37, 38, 66) . Furthermore, these receptors are expressed in the primary VM neurons used in the present studies (Costantini, unpublished observations).
Role of Phosphorylation in Elongation or Branching of DA Neurites
We observed enhanced elongation with immunophilin ligands that inhibit the phosphatase activity of calcineurin (48) through their binding to their respective immunophilins (31, 32) , as well as with GDNF which requires phosphorylation for its trophic effects (35) . Calcineurin is expressed in the substantia nigra (13, 27) , and its inhibition maintains the phosphorylation levels of several substrates (12, 28, 42, 52, 64, 68) that are critically involved in neuronal outgrowth (51, 54) . Moreover, inhibition of calcineurin by a FK506 analog (ascomycin) stabilized F-actin in cultured hippocampal neurons (30) , suggesting a role for calcineurin in cytoskeletal systems during neurite elongation (28) .
In our study, the elongation observed with ligands inhibiting calcineurin was also observed with GDNF. The GDNF receptor system consists of GDNF family receptor ␣1 (GFR ␣1) and the tyrosine kinase Ret (39), both of which are expressed in developing VM (4, 18, 74, 79) . Activation of Ret tyrosine kinase activity by GDNF results in formation of neuritogenesis-associated lamellipodia (75) , and tyrosine kinase inhibitors suppress GDNF-induced neurite outgrowth in cell lines (35) . Thus, the compounds in our study that showed enhanced elongation of DA neurites are known to maintain phosphorylation levels within the cell, either through kinase activation (GDNF) or through inhibition of calcineurin (FK506 and CsA). Assays determining phosphorylation states of growth-associated proteins, such as GAP43 (6), microtubule-associated proteins (45) , nitric oxide synthase (12), actin depolymerization factor (56) , and GTPases (23) are required to fully evaluate this hypothesis. Alternatively, the folding of cytoskeletal proteins, receptors, or ion channels (33) through the rotamase-inhibitory effects of immunophilin ligands may alter extension and branching of developing neurites (32, 33) .
Given the enhanced branching of DA neurites observed with rapamycin and V-10,367, a mechanism independent of calcineurin inhibition for trophic effects must be in play. Other evidence supporting a calcineurin-independent trophic mechanism is the neuroprotection and regeneration observed with immunophilin ligands that do not inhibit calcineurin (10, 26, 67) . We investigated the role of calcineurin in these growth-promoting effects by combining either V-10,367 or rapamycin with FK506. Rapamycin is a competitive inhibitor of FK506 due to its higher affinity for FKBP12 (15) (and we found that rapamycin produced its trophic effects on DA neurites at concentrations lower than those of FK506, reflecting a higher potency). Both rapamycin and V-10,367 antagonized the effects of FK506 on elongation, presumably by competing for FKBP12-binding sites and decreasing the ability of FK506 to inhibit calcineurin. At the lower doses of competing V-10,367 and rapamycin, FK506-induced elongation was blocked but no branching occurred. However, at the higher doses of V-10,367 and rapamycin, branching did occur, even in the presence of FK506. These results support the requirement for maintained phosphorylation to obtain enhanced elongation of DA neurites.
The antagonism of elongation (and reappearance of branching) elucidate the intrinsic abilities of developing DA neurons to either elongate or branch, but not both. During development, when DA axons reach their target, they stop elongating and begin to branch extensively (57) . Growth cone motility is directly related to neurite branching and stabilizes outgrowth by holding elongation rate at a submaximal level (55) . In this way, under conditions of neurite branching (as with V-10,367 and rapamycin), neurites would show reduced elongation.
In contrast to our observations, the enhancement of NGF-induced outgrowth from PC12 cells and DRG by FK506 was not blocked by rapamycin, yet rapamycin alone enhanced outgrowth in these systems (50, 70) . In a separate study, FK506 and CsA inhibited the NGFinduced neurite extension and neuritogenesis from DRG, while rapamycin inhibited only extension (9) . The intracellular pathways present in PC12 and DRG cells are different than those in the primary DA culture system used in the present study, in which we observe rapamycin-associated pathways contributing to increased branching of DA neurites.
In conclusion, this study provides insight into the growth-promoting effects of immunophilin ligands on the DA system. Dopaminergic neurons of the substantia nigra start elongating axons toward their striatal target soon after final differentiation around Embryonic Day 12; then these axons branch extensively to innervate the striatum (76) . During this phase, the developing neuron (both in culture and in brain) is expressing and responding to specific proteins that affect neuritogenesis and elongation (6, 17) . The contrasting effects we observed on branching and elongation by different immunophilin ligands and GDNF suggest that these molecules differentially modify the activities, expression, or structural states of proteins involved in neurite outgrowth. These observations may be relevant to recent trophic effects observed in vivo with immunophilin ligands (10, 26, 67) . Additional studies are required to further elucidate the biochemical and molecular pathways involved in these growthpromoting effects.
